← Back to Newsletter Archive

Greetings!

Welcome to the QPS Pharmacology Newsletter


Explore how the QPS IND Package can accelerate your pharmacology studies, advance your psoriasis drug development, and stay ahead with fresh insights on innovations like mRNA vaccines and the gut‑brain connection to Alzheimer’s on the QPS Blog.

Accelerate Your Path to IND Success

QPS provides a fully coordinated suite of pharmacology, toxicology, and ADME services designed to reduce delays, strengthen your regulatory package, and give you confidence as you advance toward first‑in‑human trials.


QPS’ IND Package is built to move your drug candidate forward faster, giving you a clear, expertly guided path from early studies to IND/CTA submission.

Download the White Paper

Confidently Choose A CRO to Support Your IND Efforts

Advance Psoriasis Drug Development with Confidence

Advance your psoriasis drug development with the QPS Imiquimod (IMQ)-induced psoriasis model, designed to generate reliable preclinical efficacy data in a well-established model of inflammatory skin disease.


Our experienced pharmacology team helps you rapidly evaluate therapeutic candidates, supporting confident decisions and keeping your development program on track.

Discover the Future of Science on the QPS Blog

mRNA Vaccines: Cancer, Autoimmune Disease, and Beyond


A single class of drug has the potential to treat infectious diseases, zoonotic diseases, autoimmune diseases, and even cancer.


Innovation in mRNA Vaccines

Gene Therapy at QPS

Inside the Gut-Brain Connection in Alzheimer's Disease

 

The human gut contains approximately 100 trillion microorganisms that help regulate digestion, metabolism, immunity and nervous system signaling.


The Balance Between Gut and Brain

Clinical Trials at QPS

Contact the Experts at QPS


Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today to explore how we can help accelerate your next drug development program.

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

Linkedin  Youtube  X  Facebook  

View as Webpage

www.qps.cominfopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive